Research Article
ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme
Figure 7
ADAMTSL4 predicted worse survival in GBM (WHO grade IV). The overall survival of high- and low-ADAMTSL4 expression in the CGGA (a), TCGA (b), REMBRANDT (c), and GSE16011 (d) databases is quite different.
(a) CGGA |
(b) TCGA |
(c) GSE16011 |
(d) REMBRANDT |